EMA — authorised 25 March 2022
- Marketing authorisation holder: AstraZeneca AB
- Status: approved
🇪🇺 CILGAVIMAB in European Union
EMA authorised CILGAVIMAB on 25 March 2022
Marketing authorisation
CILGAVIMAB in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in European Union
Frequently asked questions
Is CILGAVIMAB approved in European Union?
Yes. EMA authorised it on 25 March 2022.
Who is the marketing authorisation holder for CILGAVIMAB in European Union?
AstraZeneca AB holds the EU marketing authorisation.